Literature DB >> 1968397

Cryopreservation of human brain tissue.

R J Robbins1, I Torres-Aleman, C Lebranth, C W Bradberry, A Y Deutch, S Welsh, R H Roth, D Spencer, D E Redmond, F Naftolin.   

Abstract

Tissues from products of conception were examined to determine the feasibility of obtaining viable neural tissue after suction abortion at 9-12 weeks of gestation. The ventral mesencephalon, a prototype region whose maturation can be monitored and which is a potential tissue for transplantation, was identified in 32 of 120 cases. The tissue was then screened for the presence of infectious agents, while being held at -196 degrees C in cryopreservative solutions. Three of 32 specimens were found to be contaminated by normal vaginal bacteria; all other viral, fungal, and mycoplasma testing was negative. Thawed brain fragments retained high viability after storage in liquid nitrogen and when grown in vitro exhibited neuronal morphology, tyrosine hydroxylase immunoreactivity, and dopamine production. We have demonstrated that human fetal brain tissue can be cryopreserved in a manner which not only retains viability but allows normal phenotypic differentiation after thawing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968397     DOI: 10.1016/0014-4886(90)90137-h

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  3 in total

1.  Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease.

Authors:  H Sauer; E M Frodl; A Kupsch; G ten Bruggencate; W H Oertel
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Cryopreservation and culture of the human fetal brain tissues.

Authors:  R S Cai; D L Xue; X H Jiang
Journal:  J Tongji Med Univ       Date:  1993

3.  Cryopreservation of cortical tissue blocks for the generation of highly enriched neuronal cultures.

Authors:  Ardeshir S Rahman; Shaudee Parvinjah; Michael A Hanna; Pablo R Helguera; Jorge Busciglio
Journal:  J Vis Exp       Date:  2010-11-11       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.